hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet [Urimar Reformulated Oct 2013]
RxNorm concept 1440875, branded drug (sbd). Prescribable name: URIMAR-T 120 MG / 40.8 MG / 36.2 MG / 10.8 MG / 0.12 MG Oral Tablet, Reformulated Oct 2013.
- RxCUI
- 1440875
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/1440875 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
- methenamine 6832
- methylene blue 6878
- phenyl salicylate 36122
- hyoscyamine 153970
- sodium phosphate, monobasic 235496
Other names
Urimar-T (Hyoscyamine Sulfate 0.12 MG / Methenamine 120 MG / Methylene blue 10.8 MG / phenyl salicylate 36.2 MG / Sodium Phosphate, Monobasic 40.8 MG) Oral Tablet, Reformulated Oct 2013
Related concepts
- phenyl salicylate 36.2 MG (SCDC, consists of)
- methenamine 120 MG (SCDC, consists of)
- methylene blue 10.8 MG (SCDC, consists of)
- sodium phosphate, monobasic 40.8 MG (SCDC, consists of)
- hyoscyamine sulfate 0.12 MG (SCDC, consists of)
- hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG [Urimar Reformulated Oct 2013] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Urimar Reformulated Oct 2013 (BN, has ingredient)
- hyoscyamine sulfate 0.12 MG / methenamine 120 MG / methylene blue 10.8 MG / phenyl salicylate 36.2 MG / sodium phosphate, monobasic 40.8 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 79043033401
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 1440875 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/1440875 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 1440875. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.